Core Insights - SS&C Technologies reported record fourth-quarter results with adjusted revenue of $1.655 billion, an 8% increase year-over-year, and adjusted diluted earnings per share of $1.69, up 18% [4][7] - The company anticipates continued organic growth and margin expansion in 2026, with guidance for revenue between $6.65 billion and $6.74 billion and adjusted EPS between $6.70 and $7.02 [5][18] Financial Performance - GAAP fourth-quarter revenue was $1.654 billion, with net income of $193 million or $0.77 per diluted share [1] - Adjusted net income was $425 million, reflecting a 16.8% increase, and adjusted consolidated EBITDA reached $651 million, up 9% with a margin of 39.3% [4][8] - Operating cash flow for the year was $1.745 billion, with cash-flow conversion exceeding 100% for three consecutive years [6][9] Growth Drivers - Adjusted organic revenue growth for the quarter was 5.3% on a constant-currency basis, driven by strong performance in Global Investor & Distribution Solutions (GIDS) and GlobeOp, with revenue increases of 13.2% and 9.6% respectively [3] - The company is focusing on international growth, particularly in Australia, leveraging opportunities tied to recent superannuation mandates [3] Shareholder Returns - SS&C returned $384 million to shareholders in Q4, including $319 million in share repurchases and $66 million in dividends [10] - The company repurchased over $1 billion of stock in 2025, indicating a strong commitment to share buybacks in the absence of high-quality acquisition opportunities [6][10] Strategic Initiatives - Management views outsourcing and "lift-outs" as sustainable growth engines, with ongoing integration of the Calastone acquisition [5][12] - AI is considered a competitive advantage, with SS&C deploying AI solutions rapidly, leveraging its proprietary software and data [14][15] 2026 Outlook - The company expects to maintain strong performance throughout 2026, with guidance reflecting a focus on expense management, productivity, and technology leverage [16][17] - Q1 2026 guidance includes revenue of $1.608 billion to $1.648 billion and adjusted net income of $404 million to $420 million [18]

Financial Data and Key Metrics Changes - SS&C Technologies reported record adjusted revenue of $1.655 billion for Q4 2025, an increase of 8% year-over-year, and adjusted diluted earnings per share of $1.69, reflecting an 18% increase [5][10] - Adjusted consolidated EBITDA reached a record $651 million, up 9%, with an adjusted EBITDA margin of 39.3% [5][11] - Cash from operating activities for the full year was $1.745 billion, up 26% year-over-year, with operating cash flow per share at $6.89, an increase of $1.42 from 2024 [6][12] Business Line Data and Key Metrics Changes - GIDS experienced a revenue growth of 13.2%, while GlobeOp saw a 9.6% revenue increase, contributing significantly to the overall performance [5][10] - Intralinks showed signs of improvement with modest growth in Q4, indicating potential momentum for 2026 [6] Market Data and Key Metrics Changes - The company is focusing on international growth opportunities, particularly in Australia, leveraging recent superannuation mandates [5] - The healthcare business is viewed as a long-term play, with expectations for future growth despite current headwinds [20] Company Strategy and Development Direction - The company is optimistic about the AI boom, viewing it as a tailwind for growth, and is rapidly deploying AI solutions to enhance efficiency and scalability [4][9] - SS&C is prioritizing share repurchases and is open to high-quality, accretive acquisitions, with over $1 billion allocated for share repurchases in 2025 [6][7] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the durability of growth drivers, emphasizing long-term partnerships that create recurring revenue [8][9] - The company anticipates continued strong performance in 2026, with guidance for revenue in the range of $6.65 billion to $6.74 billion and organic growth of 5.1% at the midpoint [15][16] Other Important Information - The effective non-GAAP tax rate for Q4 2025 was 19.2%, with a full-year effective tax rate of 22% [12] - The company ended Q4 with $462 million in cash and cash equivalents and a net debt of $7 billion, resulting in a net leverage ratio of 2.8 times [13] Q&A Session Summary Question: What drove the weakness in the healthcare business? - Management noted that healthcare is a long-term play and highlighted the lumpy nature of large license sales, with optimism for future growth due to new technology [20][21] Question: Update on the Elevance relationship? - Management indicated that DomaniRx is ready for onboarding, but challenges exist due to the size and complexity of Elevance's existing relationships [22] Question: Insights on alternative fund administration growth? - Management confirmed strong organic growth in the alternative fund administration sector, with expectations for continued growth in 2026, partly driven by the acquisition of Curo Fund Services [25] Question: Outlook for the intelligent automation business? - Management expressed optimism for the intelligent automation business, noting that it is a key area for innovation and growth, particularly with AI advancements [26][27] Question: Organic growth guidance for 2026? - Management stated that the consistent organic growth guidance reflects a stronger business with more predictability and recurring revenue [31] Question: Competitive advantage against emerging AI fintechs? - Management emphasized the challenges of building a large organization compared to starting a fintech, highlighting the importance of regulatory compliance and established client relationships [32][33] Question: Medium-term outlook for wealth and investment management? - Management expressed optimism for the wealth management business, citing the strength of the Black Diamond platform and ongoing integration efforts [36][38] Question: M&A environment insights? - Management indicated ongoing interest in acquisitions, noting that they are well-positioned to pursue larger opportunities if the right targets are identified [39][40]

Financial Data and Key Metrics Changes - The company reported record adjusted revenue of $1.569 billion, an increase of 7% year-over-year, and adjusted diluted earnings per share of $1.57, reflecting a 17.2% increase [5][12] - Adjusted consolidated EBITDA reached $619 million, up 9.3%, resulting in a quarterly adjusted consolidated EBITDA margin of 39.5% [5][13] - Cash from operating activities for the nine months ended September 30, 2025, was $1.101 billion, a 22% increase over the prior year [6][15] - The company returned $305 million to shareholders in Q3, including $240 million for share repurchases and $65.8 million in dividends [6][7] Business Line Data and Key Metrics Changes - The GIDS business experienced a 9% revenue growth, while GlobeOp reported a 9.6% revenue growth, contributing to the overall performance [5][12] - Financial services recurring revenue growth was 6.7% in Q3 [5] Market Data and Key Metrics Changes - The company noted strength across all alternative markets and capitalized on international opportunities, particularly in Australia and the U.S. [5][10] - The acquisition of Curo Fund Services is expected to enhance the company's presence in the African market, which is still developing compared to European and U.S. markets [7][26] Company Strategy and Development Direction - The company aims to enhance user interfaces and client experiences as competitive differentiators, particularly through emerging technologies [10] - Intelligent automation and AI are viewed as both revenue opportunities and means to improve operational efficiency [9][10] - The company is focused on high-quality acquisitions and has recently completed the acquisition of Calastone, which adds capabilities in money markets, ETFs, and digital assets [8][7] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the fourth quarter, expecting revenue in the range of $1.59 billion to $1.63 billion and organic revenue growth of 4.5% at the midpoint [16][17] - The company anticipates continued strong performance in 2026, supported by a robust pipeline of liftouts and acquisitions [23][10] Other Important Information - The company raised its common stock dividend to $1.08, an 8% increase [7] - The effective non-GAAP tax rate was reported at 21.1% [13] Q&A Session Summary Question: Contribution of Battea to Q4 organic growth - Management expects Battea to contribute approximately $25 million in Q4, up from $16 million in the previous year [21] Question: Details on organic growth mechanics - A significant portion of organic growth was attributed to a large liftout in Sydney, Australia, completed on July 1 [23] Question: Revenue generation from Curo Fund Services - Curo is generating negligible revenue, approximately $15 million [27] Question: Update on agentic AI implementation - The company is infusing AI agents across its business, enhancing existing technologies with smarter capabilities [28] Question: Impact of lost business from State Street - Management indicated a small impact from lost business but remains confident in overall growth [31] Question: Margin outlook with GIDS and GlobeOp growth - The company expects continued margin improvement, driven by strong performance in GlobeOp and efforts to enhance GIDS margins [32] Question: Seasonality of Calastone's revenue - Management stated that Calastone does not have significant seasonality that would impact overall growth rates [39] Question: Confidence in healthcare business growth - Management expressed cautious optimism about the healthcare business, noting its lumpy nature but strong client relationships [43]

Financial Data and Key Metrics Changes - The company reported record adjusted revenue of $1.569 billion, an increase of 7% year-over-year, and adjusted diluted earnings per share of $1.57, reflecting a 17.2% increase [5][12] - Adjusted consolidated EBITDA reached $619 million, up 9.3%, resulting in a quarterly adjusted consolidated EBITDA margin of 39.5% [5][13] - Cash from operating activities for the nine months ended September 30, 2025, was $1.101 billion, a 22% increase over the prior year [6][15] - The company returned $305 million to shareholders in Q3, including $240 million for share repurchases and $65.8 million in dividends [6][7] Business Line Data and Key Metrics Changes - The GIDS business experienced a 9% revenue growth, while GlobeOp reported a 9.6% revenue growth, contributing to the overall performance [5][12] - Financial services recurring revenue growth was 6.7% in Q3 [5] Market Data and Key Metrics Changes - The company noted strength across all alternative markets and capitalized on international opportunities, particularly in Australia and the U.S. [5][10] - The acquisition of Curo Fund Services is expected to enhance the company's presence in the African market, which is still developing compared to Europe and the U.S. [7][26] Company Strategy and Development Direction - The company aims to enhance user interfaces and client experiences as competitive differentiators, particularly through emerging technologies [10] - Intelligent automation and AI are viewed as both revenue opportunities and means to improve operational efficiency [9][10] - The company is focused on high-quality acquisitions and has recently completed the acquisition of Calastone, which adds capabilities in money markets, ETFs, and digital assets [8][7] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the fourth quarter and the remainder of the year, expecting continued strong performance [15][18] - The company anticipates revenue growth of approximately 4.5% in Q4 and has raised its full-year revenue guidance [17][18] - Management acknowledged the competitive landscape but remains confident in the company's growth trajectory despite some lost business [31][32] Other Important Information - The company is hosting its annual Deliver Conference, which will showcase its latest offerings and advancements in AI [18] - The effective non-GAAP tax rate was reported at 21.1% for the quarter [13] Q&A Session Summary Question: Contribution of Pathea to Q4 organic growth - Management expects Pathea to contribute approximately $25 million in Q4, up from $16 million in the previous year [20][21] Question: Details on organic growth mechanics - A significant portion of organic growth was attributed to a large liftout in Sydney, Australia, completed on July 1 [22][23] Question: Curo Fund Services deal attraction and revenue - The African market's potential and existing relationships with large insurers were key attractions, with Curo generating approximately $15 million in revenue [26][27] Question: Update on agentic AI implementation - The company is integrating AI across its business, enhancing existing technologies with smarter agents [28] Question: Impact of lost business from State Street - Management indicated a small impact from lost business but remains confident in overall growth [31] Question: Margin outlook with GIDS and GlobeOp growth - The company expects continued margin improvement due to strong performance from GlobeOp and efforts to enhance GIDS margins [32] Question: Seasonality of Calastone's revenue - Management stated that Calastone does not have significant seasonality that would impact overall growth rates [39] Question: M&A pipeline and Intralinks growth - Early indicators show improvement in the M&A pipeline, although revenue growth may lag behind [42] Question: Confidence in healthcare business growth - Management expressed cautious optimism about the healthcare business, highlighting its potential for large deals [43]

Financial Data and Key Metrics Changes - The company reported record adjusted revenue of $1,569 million, a 7% increase year-over-year, and adjusted diluted earnings per share of $1.57, reflecting a 17.2% increase [5][14] - Adjusted consolidated EBITDA reached $619 million, up 9.3%, with a quarterly adjusted consolidated EBITDA margin of 39.5% [5][14] - Cash from operating activities for the nine months ended September 30, 2025, was $1,101 million, a 22% increase over the prior year [6][16] Business Line Data and Key Metrics Changes - The Global Investor and Distribution Services (GIDS) business experienced a 9% revenue growth, while GlobeOp reported a 9.6% revenue growth [5][14] - Financial services recurring revenue growth was 6.7% in Q3 [6] Market Data and Key Metrics Changes - The company noted strength across all alternative markets and capitalized on international opportunities, particularly in Australia and the U.S. [5][6] Company Strategy and Development Direction - The company is focused on intelligent automation and AI as both a revenue opportunity and a means to enhance operational efficiency [11] - Recent acquisitions, including Kural Fund Services and Callistone, are aimed at expanding the company's market presence and capabilities, particularly in the African market and digital assets [8][9] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the fourth quarter, expecting continued growth and improved margins, while also acknowledging the competitive landscape [17][19] - The company anticipates revenue for 2025 to be in the range of $6,210 million to $6,250 million, with an organic revenue growth of 4.6% at the midpoint [17][18] Other Important Information - The company returned $305 million to shareholders in Q3, including share repurchases and dividends, and raised its common stock dividend by 8% to $1.8 [7][14] - The company ended Q3 with $388 million in cash and cash equivalents and $6.6 billion in gross debt, resulting in a net leverage ratio of 2.59 times [16] Q&A Session Summary Question: Contribution of Batea to Q4 organic growth - Management expects Batea to contribute approximately $25 million in Q4, up from $16 million in the previous year [22][23] Question: Mechanics behind GIDS organic growth - The organic growth was significantly driven by a large lift out completed in Sydney, Australia, and other successful lift outs [25][27] Question: Attractiveness of CuraFund services deal - The African market is still developing in fund administration, and the acquisition is expected to enhance relationships with large insurers [30][32] Question: Impact of lost business from State Street - Management indicated a small impact on revenue but emphasized that the WIP business will continue to grow [37] Question: Margin outlook with GIDS and GlobeOp growth - The strength of GlobeOp's margins contributed positively, and overall margin improvement is expected to continue [38] Question: Seasonality of Callistone's revenue - Management stated that there is no significant seasonality in Callistone's revenue that would impact growth rates [46] Question: Pipeline for Intralinks and competitive landscape - Early indicators of pipeline improvement were noted, although growth has not yet translated into improved results [48] Question: Confidence in healthcare business growth - Management expressed confidence in the healthcare business, citing strong client relationships and ongoing development efforts [50]